5Pazzi P, Scagliarini R, Puviani AC, et al. Biochemical assessment and clinicalevaluation of a non - ionieadsorbent resin in patients with intractable jaundice [ J ]. Int J Artif Organs, 2000,23 ( 5 ) : 312 -318.
4Bagshaw SM,Laupland KB,Boiteau PJ,et al.ls regional citratesuperior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system[J].J Crit Care,2005,20:155-161.
6Murray PT,Reddy BY,Grossman EJ,et al.A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease[J].Kidney Int,2004,66:2446-2453.
7Amanzadeh J,Reilly RF Jr.Anticoagulation and continuous renal replacement therapy[J].Semin Dial,2006,19(4):311-316.
8Hetzel GR,Sucker C.The heparin:all a nephrologist should know[J].Nephrol Dial Transplant,2005,20:2036-2042.
9Wiemer J,Winkler K,Baumstark M,et al.Influence of low molecular weight heparin compared to conventional heparin for anticoagulation during haemo-dialysis on low density lipoprotein subclasses[J].Nephrol Dial Transplant,2002,17:2231-2238.
